Effect of ondansetron, a 5-HT(3) receptor antagonist, on fatigue in chronic hepatitis C: a randomised, double blind, placebo controlled study

Background and aims: There are no available effective therapies for fatigue associated with chronic hepatitis C (CHC). The serotonin antagonist ondansetron has been shown to be effective in the chronic fatigue syndrome. In this randomised, placebo controlled, double blind trial, we investigated the...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Piche, T, Vanbiervliet, G, Cherikh, F, Antoun, Z, Huet, P M, Gelsi, E, Demarquay, J-F, Caroli-Bosc, F-X, Benzaken, S, Rigault, M-C, Renou, C, Rampal, P, Tran, A
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Copyright 2005 by Gut 2005
Aiheet:
Viral Hepatitis
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC1774898/
https://ncbi.nlm.nih.gov/pubmed/16009690
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.2004.055251
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia